Healthcare Social Media and Updates

AI Model Detects Pre‑Symptom Alzheimer’s Fingerprint
SocialApr 29, 2026

AI Model Detects Pre‑Symptom Alzheimer’s Fingerprint

𝐀𝐈 𝐅𝐨𝐮𝐧𝐝 𝐭𝐡𝐞 𝐊𝐞𝐲 𝐭𝐨 𝐏𝐫𝐞-𝐒𝐲𝐦𝐩𝐭𝐨𝐦 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 #FINGERPRINT Introducing #FINGERS7B, the first AI foundation model designed specifically to prevent Alzheimer’s disease via @NeuroscienceNew https://t.co/J7XKdg7drF https://t.co/QQKyverDNZ

By Brian Ahier
Marriage Cuts Cancer Risk, Especially for Women
SocialApr 29, 2026

Marriage Cuts Cancer Risk, Especially for Women

🚨New Study: Marriage more protective against cancer for women than men @WSJ: ✔️Cancer rates 68% higher for never-married men But. . . ✔️Cancer rates 83% higher for never-married men https://t.co/eQcmo0pa4B

By W. Bradford Wilcox
Apple Vision Pro Powers First VR-Assisted Surgery, Heralding Medical Future
SocialApr 29, 2026

Apple Vision Pro Powers First VR-Assisted Surgery, Heralding Medical Future

‘Safer, smarter, and more connected’: Apple’s Vision Pro used in world-first VR-assisted surgery, and it could be the future of medicine https://www.techradar.com/computing/virtual-reality-augmented-reality/safer-smarter-and-more-connected-apples-vision-pro-used-in-world-first-vr-assisted-surgery-and-it-could-be-the-future-of-medicine

By Lance Ulanoff
Check Your Hearing Early with Dr. Rufina Yakubov
SocialApr 29, 2026

Check Your Hearing Early with Dr. Rufina Yakubov

What a great healer, Doctor Rufina Yakubov fifthavenuehearing an audiologist who helps many of us participate and bask in the aural landscape that is life. Check your hearing. Please. Many put this off and begin to do real neurological...

By Jerry Saltz
Investigate Who Profits From Overprescribing SSRIs, Like Opioids
SocialApr 29, 2026

Investigate Who Profits From Overprescribing SSRIs, Like Opioids

We should find out who's really responsible for doctorss prescribing so many SSRIs We have to follow the money Just like they did with the opioids epidemic

By Pieter Levels
Six-Step Playbook for Risk‑Stratified Lipid‑Lowering Therapy
SocialApr 29, 2026

Six-Step Playbook for Risk‑Stratified Lipid‑Lowering Therapy

Reducing cardiovascular risk: a playbook for lipid-lowering pharmacotherapy Risk-stratified targets and a six-step playbook for choosing, combining, and escalating lipid-lowering therapy https://t.co/PcIQNxmivX https://t.co/SzTN9ZAD85

By David Barzilai, MD PhD
Arcade Game Distraction Makes Kids' Vaccinations Painless
SocialApr 29, 2026

Arcade Game Distraction Makes Kids' Vaccinations Painless

Distraction can soothe the experience of so many medical procedures, especially for kids. This video from a Chinese physician shows how he could give the child two vaccines while he was playing with an arcade game. I'd love to use the same...

By Bertalan Meskó, PhD
Quantum Algorithm Generates Valid KRAS Inhibitor Hits
SocialApr 29, 2026

Quantum Algorithm Generates Valid KRAS Inhibitor Hits

Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors 👉 “We introduce a quantum–classical generative model for small-molecule design… his work showcases the potential of quantum computing to generate experimentally validated hits that compare favorably against classical models. @biogerontology https://t.co/s7LjNpu2CP

By David Barzilai, MD PhD
ONC Secures $20M for Huahi's Hexavalent Trispecific
SocialApr 29, 2026

ONC Secures $20M for Huahi's Hexavalent Trispecific

If you're wondering what $ONC got for its $20 m, here's the #AACR25 detail on Huahi's HH160, a symmetrical hexavalent trispecific anti PD-1 x CTLA-4 x VEGF-A MAb https://t.co/Y0jVjTuMMo

By Jacob Plieth
Gill’s Questions Won’t Shift Reproductive‑rights Opinions
SocialApr 29, 2026

Gill’s Questions Won’t Shift Reproductive‑rights Opinions

Wow. Who could not want to re-evaluate their stance on abortkon - otherwise known as "reproductive rights" after Congressman Brandon Gill's questions.

By Guy Spier
Low‑Quality Studies Mislead Clinical Decisions, Women Deserve Better
SocialApr 29, 2026

Low‑Quality Studies Mislead Clinical Decisions, Women Deserve Better

I said what I said. Telling people that methodologically low quality studies are important work for clinical decisions is not science. They may reinforce someone’s pet and financially profitable hypothesis. there’s a big problem in medicine or people put out...

By Jen Gunter, MD
AI Detects Hidden Pancreatic Cancer at 73% Accuracy
SocialApr 29, 2026

AI Detects Hidden Pancreatic Cancer at 73% Accuracy

An AI that detects occult pancreatic cancer better than radiologists (73 vs 39%) via CT with external validation https://t.co/NIiIFjlyxp https://t.co/8aVAmy0eFl

By Eric Topol
Longevity and AI Lead Disruptive Tech Conversation at BofA
SocialApr 29, 2026

Longevity and AI Lead Disruptive Tech Conversation at BofA

The annual Bank of America event on disruptive technologies was amazing and insightful as usual. Key technologies were Longevity and AI drug discovery (what I care about the most), Brain-Compute Interfaces (I also care about it very much), Space, Electric...

By Alex Zhavoronkov, PhD
Boosting T Helper Cells Could Curb Lifelong Viral Infections
SocialApr 28, 2026

Boosting T Helper Cells Could Curb Lifelong Viral Infections

The immune system actively combats lifelong viral infections acquired at birth, but its response is limited by a reduced pool of T helper cells; enhancing these cells may offer new therapeutic strategies. immunology

By Phys.org Threads
Nicotinamide Boosts NK Cells, Induces NHL Remissions
SocialApr 28, 2026

Nicotinamide Boosts NK Cells, Induces NHL Remissions

Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma https://t.co/VrC2ertsVd

By Michael Lustgarten, PhD
NVO’s 4.4% Yield Boosted by Oral Semaglutide Surge
SocialApr 28, 2026

NVO’s 4.4% Yield Boosted by Oral Semaglutide Surge

$NVO pays a decent 4.4% dividend and oral semaglutide is surging: "First-time anti-obesity medication (AOM) prescribing increased 21.7% from December 2025 to March 2026, with first-time AOM semaglutide prescribing increasing by more than 50%. AOM semaglutide also showed its largest quarter-over-quarter percentage...

By Peter Suzman
Living Vessel ATEV Offers New Hope for Dialysis Access
SocialApr 28, 2026

Living Vessel ATEV Offers New Hope for Dialysis Access

Humacyte’s ATEV could change the game for dialysis patients who run out of fistula options. It’s a living vessel that resists infection and needs fewer repairs. Major unmet need, big potential. Biotech

By periodtrader
Hire Passion, Not Experience, to Cut Medicare Costs
SocialApr 28, 2026

Hire Passion, Not Experience, to Cut Medicare Costs

"No one is waking up every day thinking about Medicare." They work to save seniors $1,100-plus annually on their Medicare. But Chapter CEO Cobi Blumenfeld-Gantz says he's never hired someone from the healthcare industry. Instead, Chapter hires for people excited about working...

By Alex Konrad
Real‑World OmegaAI Workflow: Beyond Demo Perfection
SocialApr 28, 2026

Real‑World OmegaAI Workflow: Beyond Demo Perfection

Most demos show you the perfect path. But what does the software actually feel like to use? This hands-on look at RamSoft’s OmegaAI + Blume pulls back the curtain—no fluff, just real workflow insights. 🔗 https://t.co/F9IGWOx3zl @Ramsoft #RadiologyWorkflow #healthtech

By Colin Hung
Proposing Medicare Over Medicaid for Home-Based Long-Term Care
SocialApr 28, 2026

Proposing Medicare Over Medicaid for Home-Based Long-Term Care

My look at a plan to shift home and community based long-term care from Medicaid to Medicare https://t.co/kIHQ5jBHJ3 #medicare #medicaid #seniors #hcbs #longtermcare #peoplewithdisabilities

By Howard Gleckman
Apple Vision Pro Enables First Spatial-Computing Cataract Surgery
SocialApr 28, 2026

Apple Vision Pro Enables First Spatial-Computing Cataract Surgery

An ophthalmologist in San Diego just performed the first Apple Vision Pro-assisted cataract eye surgery. Dr. Tommy Korn (aka medicine's first "chief spatial computing medical officer") did it as part of a clinical study. Main benefits are easy access to patient info (visual...

By Trung Phan
FDA Partners with AZN, AMGN to Accelerate AI-Driven Trials
SocialApr 28, 2026

FDA Partners with AZN, AMGN to Accelerate AI-Driven Trials

FDA launches effort with $AZN $AMGN to speed up clinical trials, using AI https://t.co/k4LjxnDLmq via @LizzyLaw_

By Adam Feuerstein
Supreme Court Case Could Broaden Vascepa Generic Labeling
SocialApr 28, 2026

Supreme Court Case Could Broaden Vascepa Generic Labeling

Vascepa "skinny label" generic case at the Supreme Court. The generic label is only for hypertriglyceridemia, while Vascepa label is much broader. But gets promoted as a generic for Vascepa. Impact might be substantial. https://t.co/xtGWtscXkc

By Peter Suzman
Medevac Helicopters Use Roadside LZs for Familiarization Flights
SocialApr 28, 2026

Medevac Helicopters Use Roadside LZs for Familiarization Flights

There are a lot of reasons a helo, esp a medevac, would land next to a road. One common reason is that medical helicopters will conduct familiarization flights and land at pre-approved LZs (some of which are private) in their...

By Nathan Strang
Hospitals Prioritize Profit Over People in Health Policy
SocialApr 28, 2026

Hospitals Prioritize Profit Over People in Health Policy

Quick reminder that hospitals are not on the side of the people when it comes to health policy

By Rhet Lage (public health advocate)
Endurance Exercise Protects Joints, Boosts Fat Oxidation
SocialApr 28, 2026

Endurance Exercise Protects Joints, Boosts Fat Oxidation

Ha... no. He's wrong. Yes, there's an Afib signal. But his other conclusions... no. Run and cycle... we know why we do it... and my patients who run/ride are by far better off than those who don't. You need...

By Howard Luks, MD
Pfizer Secures Patent Extension for Leading Rare‑Disease Drug
SocialApr 28, 2026

Pfizer Secures Patent Extension for Leading Rare‑Disease Drug

Pfizer deals extend patent life for a top-selling rare disease drug https://t.co/uXXbtLaIOL $PFE $BBIO $ALNY $IONS

By Ben Fidler
Tiny Chip Delivers High‑Bandwidth Wireless Brain Interface
SocialApr 28, 2026

Tiny Chip Delivers High‑Bandwidth Wireless Brain Interface

Ultra-Compact Brain–Computer Interface Chip Enables High-Bandwidth Wireless Neural Communication by @CUSEAS #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/gaulMV302i

By Ron van Loon
Psychedelics May Reverse Epigenetic Roots of Addiction
SocialApr 28, 2026

Psychedelics May Reverse Epigenetic Roots of Addiction

Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential these compounds may directly counteract the epigenetic and transcriptional imprints that sustain compulsive substance use https://t.co/GJyHoLPL83

By Julie Holland
RFK Jr’s Vaccine Lies Fuel Anti‑vax Agenda
SocialApr 28, 2026

RFK Jr’s Vaccine Lies Fuel Anti‑vax Agenda

RFK Jr lied about supporting vaccines last week, just as he lied about it many times before. Whatever anti-vax bullshit Bobby is peddling, holding up GAVI’s budget at the demonstrable expense of thousands of kids lives’ globally is unconscionable and...

By Angela Rasmussen
Using AI to Excuse Patient Denials Damages AI’s Reputation
SocialApr 28, 2026

Using AI to Excuse Patient Denials Damages AI’s Reputation

Letting companies use AI as a smokescreen for why patients are getting denied healthcare is going to be terrible for AI's brand https://t.co/eltFYOkih6

By Eric Newcomer
Ambient AI Revives Paper-Chart Conversation Flow, Boosts NPS
SocialApr 28, 2026

Ambient AI Revives Paper-Chart Conversation Flow, Boosts NPS

Juniper Health says ambient AI is helping bring conversations in the exam room back to something closer to the paper chart days. And patients are responding—Net Promoter Scores are at an all-time high. 🔗https://t.co/doV7kX4Zg3 @NextGen @WHClinics #JuniperHealth #HITSM https://t.co/sThLZIEPIl

By Colin Hung
Tax Nonprofit Hospitals Like For‑profit Businesses, Says W&M
SocialApr 28, 2026

Tax Nonprofit Hospitals Like For‑profit Businesses, Says W&M

Then the solution is to tax nonprofit hospitals (or hedge funds with beds) like the for-profit business they are. What is W&M waiting for?

By Scott Hodge
Introducing Peanuts at 4‑6 Months Cuts Allergies 77%
SocialApr 28, 2026

Introducing Peanuts at 4‑6 Months Cuts Allergies 77%

"Peanut allergies plummet by 77% if they're added to babies' diets at 4-6 months of age." This statistic traces back to a 2023 modeling study: Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses🥜https://t.co/SHULN2n2X5 https://t.co/CCFCt6Uguu

By David Barzilai, MD PhD
Treat AI as Strategy, Not a Tool, to Transform Healthcare
SocialApr 28, 2026

Treat AI as Strategy, Not a Tool, to Transform Healthcare

Organizations that approach AI as a strategic capability—rather than a standalone tool—will be positioned to unlock its full potential, improving care, efficiency, and patient experience. https://t.co/R0j6YngDUq

By Seema Verma
Charting FDA‑Guided Trial Pathways for Merkel Cell Carcinoma
SocialApr 28, 2026

Charting FDA‑Guided Trial Pathways for Merkel Cell Carcinoma

Really enjoyed my fireside chat at MCC4 with Harpreet Singh, MD, the CMO at Precision Medicine, focused on establishing pathways for clinical trials in Merkel cell carcinoma. The physician-scientists in the audience were clearly excited about the prospect of working...

By John Carroll
AI‑assisted Psychiatrists Match Attending Quality, Boost Accuracy
SocialApr 28, 2026

AI‑assisted Psychiatrists Match Attending Quality, Boost Accuracy

Some AI progress for mental health support seen in a real-world prospective study (<-there are few of these) "In a real-world, two-arm prospective study, resident psychiatrists assisted by PsychFound demonstrated higher consultation quality, higher diagnostic accuracy, more appropriate medication selection...

By Eric Topol
AI Protein Design Advances, Yet Developability Remains Overlooked
SocialApr 28, 2026

AI Protein Design Advances, Yet Developability Remains Overlooked

Some new protein design competition results from Rio, showing the field keeps tackling harder and harder targets w/ AI methods Might be time to factor in other properties (developability, manufacturability)? https://t.co/h1niVwjnSS

By Andrew Dunn
Healthcare Needs Early Intelligence, Not Reactive Treatment
SocialApr 28, 2026

Healthcare Needs Early Intelligence, Not Reactive Treatment

Healthcare’s version of “prevention” is often hilarious. “We noticed the problem after it became expensive. Good news: we have a brochure.” The body was dropping hints for years. Sleep. Stress. Food. Movement. Air. Labs. Wearables. Microbiome. Mood. But we built a system that waits...

By Tatyana Kanzaveli
Integrated Academic-Community Tumor Board Enhances Precision Medicine
SocialApr 28, 2026

Integrated Academic-Community Tumor Board Enhances Precision Medicine

Implementation & Utility of an Integrated Academic-Community #PrecisionMedicine Molecular Tumor Board [MTB] [Jul 5, 2017] @meburkard et al. @JCOPO_ASCO https://t.co/HOWIx826Lm https://t.co/1JmBdW6K5c

By Mike Thompson, MD PhD
First-Year Lessons Coordinating an Oncology Precision Medicine Clinic
SocialApr 28, 2026

First-Year Lessons Coordinating an Oncology Precision Medicine Clinic

Coordinating an Oncology #PrecisionMedicine Clinic w/in an Integrated Health System: Lessons Learned in Year 1 [1/28/19] @mtmdphd Godden, Wham @antonyruggeri @mullane_michael Wilson @shamsvirani Weissman, Ramczyk, Vanderwall @JimW9200 @Aurora_Cancer @JPCRR https://t.co/bxgjOfLhwk https://t.co/4pR7nFLzGW

By Mike Thompson, MD PhD
Overcoming Barriers to Community Oncology Precision Medicine
SocialApr 28, 2026

Overcoming Barriers to Community Oncology Precision Medicine

Implementing #PrecisionMedicine Programs and #ClinicalTrials in the Community-Based Oncology: Practice: Barriers and Best Practices - @JLErsek @lorablk @mtmdphd & @EdKimMDLCI #ASCO18 Education Book https://t.co/ahsmfePatk #NCORP

By Mike Thompson, MD PhD
BPL-003
SocialApr 28, 2026

BPL-003

Great piece from @Shea_ARK "AtaiBeckley is advancing BPL-003—an intra-nasal formulation derived from 5-MeO-DMT—in treatment-resistant depression, with positive Phase 2b results supporting a Phase 3 initiation in the second quarter of 2026.[11] With FDA Breakthrough Therapy designation, BPL-003 has the potential...

By Christian Angermayer
PurIST Classifier Validated for Tailored Pancreatic Cancer Therapy
SocialApr 28, 2026

PurIST Classifier Validated for Tailored Pancreatic Cancer Therapy

Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection [PurIST @TempusAI] in Pancreatic Ductal Adenocarcinoma [Sep 4, 2025] @stephwen et al. @JCOPO_ASCO https://t.co/R24DErvaB4 #pancsm #PrecisionMedicine https://t.co/KNJHtWovqT

By Mike Thompson, MD PhD
Biliary Cancer Subtypes Show Distinct Immune Signatures
SocialApr 28, 2026

Biliary Cancer Subtypes Show Distinct Immune Signatures

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/p3BzJ82oxA

By Mike Thompson, MD PhD
BRAF Class II/III Mutations Represent Unmet Clinical Need
SocialApr 28, 2026

BRAF Class II/III Mutations Represent Unmet Clinical Need

Real-world clinical genomic analysis of Pts w/ BRAF mutated cancers identifies BRAF class II & III as a population of unmet medical need [3/7/22] Severson etal #ESMO2240P @TempusAI https://t.co/s5PEBEczlv @Annals_Oncology DOI: https://t.co/c3wxWyUuX0 #PrecisionMedicine #caxtx

By Mike Thompson, MD PhD
ASCO Endorses Somatic Genomic Testing for Advanced Cancers
SocialApr 28, 2026

ASCO Endorses Somatic Genomic Testing for Advanced Cancers

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: @ASCO Provisional Clinical Opinion [Feb 17, 2022] @CDebyaniPhD et al. @JCO_ASCO https://t.co/hfHUBS3Unx #PrecisionMedicine https://t.co/GwYOMRD1hh

By Mike Thompson, MD PhD
BRAFV600E‑mutated Pediatric Gliofibroma Shows Fleeting Therapy Response
SocialApr 28, 2026

BRAFV600E‑mutated Pediatric Gliofibroma Shows Fleeting Therapy Response

Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution [Mar 27, 2019] @KanevaMD et al. @JCOPO_ASCO https://t.co/oNbfrK7EZr #PrecisionMedicine #btsm https://t.co/V7k9vEiqKm

By Mike Thompson, MD PhD
KRASG12C Mutations Linked to Distinct Immuno‑oncology Biomarkers
SocialApr 28, 2026

KRASG12C Mutations Linked to Distinct Immuno‑oncology Biomarkers

Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers [Mar 23, 2022] @SalemGIOncDoc et al. @JCOPO_ASCO https://t.co/iehC82lyA4 #ImmunoOnc #PrecisionMedicine @TempusAI https://t.co/wZzfdnBoXU

By Mike Thompson, MD PhD